HK1251180A1 - 膠束技術的生物製藥應用 - Google Patents

膠束技術的生物製藥應用

Info

Publication number
HK1251180A1
HK1251180A1 HK18110756.3A HK18110756A HK1251180A1 HK 1251180 A1 HK1251180 A1 HK 1251180A1 HK 18110756 A HK18110756 A HK 18110756A HK 1251180 A1 HK1251180 A1 HK 1251180A1
Authority
HK
Hong Kong
Prior art keywords
micell
biopharma
technology
application
micell technology
Prior art date
Application number
HK18110756.3A
Other languages
English (en)
Inventor
Wenda C Carlyle
Original Assignee
Micell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micell Technologies Inc filed Critical Micell Technologies Inc
Publication of HK1251180A1 publication Critical patent/HK1251180A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
HK18110756.3A 2015-09-09 2018-08-21 膠束技術的生物製藥應用 HK1251180A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562215998P 2015-09-09 2015-09-09
PCT/US2016/051010 WO2017044789A1 (en) 2015-09-09 2016-09-09 Biopharma application of micell technology

Publications (1)

Publication Number Publication Date
HK1251180A1 true HK1251180A1 (zh) 2019-01-25

Family

ID=56979669

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18110756.3A HK1251180A1 (zh) 2015-09-09 2018-08-21 膠束技術的生物製藥應用

Country Status (10)

Country Link
US (2) US20170065521A1 (zh)
EP (1) EP3346994A1 (zh)
JP (1) JP2018526409A (zh)
KR (1) KR20180050400A (zh)
CN (1) CN108135852A (zh)
AU (1) AU2016319782A1 (zh)
CA (1) CA2997668C (zh)
HK (1) HK1251180A1 (zh)
IL (1) IL257888A (zh)
WO (1) WO2017044789A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11406742B2 (en) 2014-07-18 2022-08-09 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757128A (en) 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US7550005B2 (en) 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
NZ520554A (en) * 2000-02-08 2005-08-26 Euro Celtique S Tamper-resistant oral opioid agonist formulations
US6780475B2 (en) 2002-05-28 2004-08-24 Battelle Memorial Institute Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions
US6756084B2 (en) 2002-05-28 2004-06-29 Battelle Memorial Institute Electrostatic deposition of particles generated from rapid expansion of supercritical fluid solutions
US6749902B2 (en) 2002-05-28 2004-06-15 Battelle Memorial Institute Methods for producing films using supercritical fluid
KR101406415B1 (ko) 2005-07-15 2014-06-19 미셀 테크놀로지즈, 인코포레이티드 제어된 형태의 약물 분말을 함유하는 중합체 코팅
PL2019657T3 (pl) * 2006-04-26 2015-10-30 Micell Technologies Inc Powłoki zawierające wiele leków
WO2008148013A1 (en) 2007-05-25 2008-12-04 Micell Technologies, Inc. Polymer films for medical device coating
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
CA2732585A1 (en) * 2008-07-30 2010-02-04 Stc.Unm Formulations containing large-size carrier particles for dry powder inhalation aerosols
CA2756386C (en) * 2009-03-23 2019-01-15 Micell Technologies, Inc. Drug delivery medical device
CA2791278C (en) * 2010-02-25 2015-11-24 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
US20150087671A1 (en) * 2012-05-16 2015-03-26 Micell Technologies, Inc. Low burst sustained release lipophilic and biologic agent compositions

Also Published As

Publication number Publication date
US20190231691A1 (en) 2019-08-01
EP3346994A1 (en) 2018-07-18
CN108135852A (zh) 2018-06-08
CA2997668C (en) 2021-06-01
US20170065521A1 (en) 2017-03-09
JP2018526409A (ja) 2018-09-13
CA2997668A1 (en) 2017-03-16
IL257888A (en) 2018-05-31
AU2016319782A1 (en) 2018-04-05
WO2017044789A1 (en) 2017-03-16
KR20180050400A (ko) 2018-05-14

Similar Documents

Publication Publication Date Title
IL283582A (en) ror - gamma modulators
HK1256599A1 (zh) ROR-γ的調節劑
HK1255699A1 (zh) Kras表達的調節劑
SG11201706729SA (en) Derivatives of sobetirome
HK1213447A1 (zh) 雙不對稱鞋子
HK1251486A1 (zh) Sestrin-gator2相互作用的調節劑和其用途
EP3512567C0 (en) CELL-SPECIFIC EXPRESSION OF MODRNA
HU4602U (en) Set of saggar assembly
IL262381A (en) 6-Aminopyridin-3-yl thiazoles as ror-gamma-t modulators
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
PT3334734T (pt) Forma c de avibactam sódico
GB201420627D0 (en) Application of adhesives
FR3024647B1 (fr) Transat de puericulture
HK1251180A1 (zh) 膠束技術的生物製藥應用
SG11201607445QA (en) Methods of modulating wars2
PT3377106T (pt) Modulação da ciliogénese
GB201519795D0 (en) Construction of surfaces
GB201418230D0 (en) Construction of surfaces
GB201511584D0 (en) Viprodi - Goblet of Fire
GB201501636D0 (en) Pair of planes
GB201413139D0 (en) Assessment of structures
GB201413138D0 (en) Assessment of structures
HUP1400294A2 (hu) Clopidogrel új alkalmazása
FR3023706B1 (fr) Orthese de genou
GB201412359D0 (en) Composition of objects